Company intelligence
ImmunoIVD AB
Swedish company developing and manufacturing CE-IVD marked molecular assays for newborn screening of SCID, SMA and XLA.
Medical Equipment Manufacturing
Nacka Strand, SE
33 employees
Founded 2015
2 public signals
About ImmunoIVD AB
Sweden-based ImmunoIVD AB is dedicated to providing reliable, accessible and innovative assays for newborn screening for SCID and SMA. Our CE IVD marked SPOT-it™ Screening Kits have been used across Europe since 2018. The assays are highly regarded for their reliability and easy-to-use workflow, requiring minimal laboratory space and equipment investment. We are recognized for our transparent communication and efficient support
Verified activity
Signals from ImmunoIVD AB
2 published signals
Presence & Recognition
ImmunoIVD AB team represented by Frida Oliv and Michalina participated in the Genomics in Newborn Screening Workshop hosted by Statens Serum Institut in Copenhagen on 10-11 September.
Reported by ImmunoIVD AB
Presence & Recognition
ImmunoIVD AB is participating in the Genomics in Newborn Screening Workshop 2026 organized by Statens Serum Institut in Copenhagen on 10-11 September.
Reported by ImmunoIVD AB